XOMA Royalty Corp
XOMA26.960USD
+0.850+3.26%
Close 07/03, 13:00（ET）Quotes delayed by 15 min
322.25MMarket Cap
LossP/E TTM
More Details of XOMA Royalty Corp Company
XOMA Royalty Corporation is a biotechnology royalty aggregator. The Company’s royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to funded partners. The Company has a portfolio of economic rights and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The Company's royalty portfolio includes OJEMDA (tovorafenib), Cetrelimab (JNJ-63723283), Ersodetug (RZ358), MIPLYFFATM (arimoclomol), Acimtamig (AFM13), Ficlatuzumab (AV-299), COM902, Vosaroxin, Aldoxorubicin, PBF-680, PBF-677, PBF-999, PBF-1129, PBF-1650, DSUVIA (sufentanil sublingual tablet), IXINITY, Vidutolimod (CMP-001), MT-0169, RZ-402, G03-52-0, AFM24, Mezagitamab (TAK-079), among others. The Company also acquires milestone and royalty revenue streams on late-stage or commercial assets.
Company Info
Ticker SymbolXOMA
Company nameXOMA Royalty Corp
IPO dateJun 06, 1986
Founded at2011
CEOMr. Owen P. Hughes, Jr.
Number of employees13
Security typeOrdinary Share
Fiscal year-endJun 06
Address2200 Powell Street
CityEMERYVILLE
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code94608
Phone15102047239
Websitehttps://www.xoma.com/
Ticker SymbolXOMA
IPO dateJun 06, 1986
Founded at2011
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Jack L. Wyszomierski
Mr. Jack L. Wyszomierski
Independent Chairman of the Board
Independent Chairman of the Board
12.44K
+92.36%
Mr. Joseph M. (Joe) Limber
Mr. Joseph M. (Joe) Limber
Independent Director
Independent Director
6.21K
-0.03%
Ms. Natasha A. Hernday
Ms. Natasha A. Hernday
Independent Director
Independent Director
5.97K
--
Ms. Heather L. Franklin
Ms. Heather L. Franklin
Independent Director
Independent Director
5.97K
--
Mr. Thomas (Tom) Burns
Mr. Thomas (Tom) Burns
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
--
--
Ms. Barbara A. Kosacz, J.D.
Ms. Barbara A. Kosacz, J.D.
Independent Director
Independent Director
--
--
Mr. Matthew D. Perry
Mr. Matthew D. Perry
Independent Director
Independent Director
--
--
Mr. Owen P. Hughes, Jr.
Mr. Owen P. Hughes, Jr.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Bradley J. (Brad) Sitko
Mr. Bradley J. (Brad) Sitko
Chief Investment Officer
Chief Investment Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Jack L. Wyszomierski
Mr. Jack L. Wyszomierski
Independent Chairman of the Board
Independent Chairman of the Board
12.44K
+92.36%
Mr. Joseph M. (Joe) Limber
Mr. Joseph M. (Joe) Limber
Independent Director
Independent Director
6.21K
-0.03%
Ms. Natasha A. Hernday
Ms. Natasha A. Hernday
Independent Director
Independent Director
5.97K
--
Ms. Heather L. Franklin
Ms. Heather L. Franklin
Independent Director
Independent Director
5.97K
--
Mr. Thomas (Tom) Burns
Mr. Thomas (Tom) Burns
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
--
--
Ms. Barbara A. Kosacz, J.D.
Ms. Barbara A. Kosacz, J.D.
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Wed, Jul 2
Currency: USDUpdated: Wed, Jul 2
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
No Data
By RegionUSD
Name
Revenue
Proportion
United States
6.09M
38.30%
Switzerland
5.82M
36.56%
Asia Pacific
4.00M
25.14%
By Business
By Region
No Data
Shareholding Stats
Updated: Thu, May 22
Updated: Thu, May 22
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BVF Partners L.P.
21.65%
Morgan Stanley Investment Management Inc. (US)
9.23%
Fidelity Management & Research Company LLC
8.68%
BlackRock Institutional Trust Company, N.A.
4.10%
The Vanguard Group, Inc.
3.84%
Other
52.51%
Shareholders
Shareholders
Proportion
BVF Partners L.P.
21.65%
Morgan Stanley Investment Management Inc. (US)
9.23%
Fidelity Management & Research Company LLC
8.68%
BlackRock Institutional Trust Company, N.A.
4.10%
The Vanguard Group, Inc.
3.84%
Other
52.51%
Shareholder Types
Shareholders
Proportion
Hedge Fund
26.12%
Investment Advisor/Hedge Fund
18.89%
Investment Advisor
17.15%
Individual Investor
1.34%
Research Firm
0.34%
Pension Fund
0.08%
Bank and Trust
0.07%
Insurance Company
0.02%
Other
35.99%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
147
7.66M
64.02%
+67.58K
2025Q1
150
7.99M
66.81%
+297.02K
2024Q4
151
7.96M
67.53%
-445.61K
2024Q3
149
7.79M
66.29%
-572.80K
2024Q2
143
7.78M
66.74%
-664.29K
2024Q1
144
7.71M
66.30%
-615.38K
2023Q4
149
7.62M
66.29%
-820.22K
2023Q3
146
7.80M
68.02%
-670.64K
2023Q2
148
7.93M
69.11%
+32.68K
2023Q1
155
7.51M
65.57%
+97.45K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BVF Partners L.P.
2.59M
21.65%
-392.72K
-13.17%
May 16, 2025
Morgan Stanley Investment Management Inc. (US)
1.10M
9.23%
+811.40K
+277.18%
Mar 31, 2025
Fidelity Management & Research Company LLC
1.04M
8.68%
-1.68K
-0.16%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
490.59K
4.1%
-8.20K
-1.64%
Mar 31, 2025
The Vanguard Group, Inc.
459.09K
3.84%
-4.75K
-1.02%
Mar 31, 2025
Opaleye Management Inc.
253.04K
2.11%
+3.04K
+1.22%
Mar 31, 2025
Geode Capital Management, L.L.C.
186.67K
1.56%
+4.48K
+2.46%
Mar 31, 2025
Woodline Partners LP
168.55K
1.41%
+12.28K
+7.86%
Mar 31, 2025
State Street Global Advisors (US)
144.73K
1.21%
+200.00
+0.14%
Mar 31, 2025
Stonepine Capital Management, LLC
129.81K
1.08%
+4.11K
+3.27%
Mar 31, 2025
View more
Related ETFs
Updated: Wed, Jul 2
Updated: Wed, Jul 2
Name
Proportion
iShares Micro-Cap ETF
0.04%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
iShares Russell 2000 Value ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Avantis US Equity ETF
0%
Avantis US Small Cap Equity ETF
0%
View more
iShares Micro-Cap ETF
Proportion0.04%
ProShares Hedge Replication ETF
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
iShares Russell 2000 Growth ETF
Proportion0.01%
iShares Russell 2000 Value ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
Avantis US Equity ETF
Proportion0%
Avantis US Small Cap Equity ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
